G
NTNX

Brian Mark Stevens

Known title: DirectorCIK: 0001778160

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 8, 2026

Genpact Highlighted in Recent Stock Analysis Articles. Recent articles from Yahoo and ChartMill have discussed Genpact as a potential option for long-term investors. These pieces focus on the company's quality and position within the services sector. The stock currently trades near a key support level, with analysts maintaining a wide range of price targets.

this person other insiders at G

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 17, 2026

Nutanix Stock Underperforms Market Amid Broker Analysis. Nutanix shares have recently declined more sharply than the broader market, drawing attention from financial analysts. Recent broker reports suggest the stock is a focus for investment strategies, while comparisons with peers like MongoDB and Google highlight its position among value-oriented tech names. The company's trailing P/E of 12.7 and average analyst target of $77.79 provide context for these ongoing discussions.

this person other insiders at NTNX

Transaction History

G▲ Buy$0
G▲ Buy$0
NTNX▲ Buy$0
G▲ Buy$0
NTNX▲ Buy$0
G▲ Buy$0
NTNX▲ Buy$0
G▲ Buy$0
NTNX▲ Buy$0

We use analytics to understand how market-wall is used. No personal data is sold.